VANI

Vivani Medical Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website vivani.com
Employees(FY) 50
ISIN US92854B1098

Performance

-9.23%

-8.53%

-4.07%

-11.28%

+15.69%

YTD

+34.58%

Profile

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Advanced Technical Analysis

Technical Analysis of VANI 2024-12-20

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 3 indicating strong downward pressure, the Oscillators Score at 43 suggesting a neutral stance, and the Technical Score at 23 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to be n...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of VANI

Stock Rank

Recent News & Updates

2024-12-19 16:11
Vivani begins exenatide implant trial for obesity in Australia(Yahoo Finance)
2024-12-18 19:30
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia(Businesswire)
2024-12-18 19:00
EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia(Yahoo Finance)
2024-12-03 19:30
Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast(Businesswire)
2024-11-12 19:35
Vivani Medical: Q3 Earnings Snapshot(Yahoo Finance)
2024-11-12 19:30
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results(Businesswire)
2024-10-29 19:00
Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now(Globenewswire)
2024-10-28 19:00
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now(Globenewswire)
2024-10-21 20:30
Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024(Businesswire)
2024-09-26 18:12
Vivani Medical obtains Australian approval to begin GLP-1 implant trial(Yahoo Finance)
2024-09-26 00:00
Vivani Medical to Test Implant in Obese and Overweight Patients(Yahoo Finance)
2024-09-25 20:30
Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia(Businesswire)
2024-09-25 20:00
EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia(Yahoo Finance)
2024-09-24 19:00
Presenting on the Emerging Growth Conference 75 Day 2 on September 26(Globenewswire)
2024-09-23 19:00
Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now(Globenewswire)
2024-09-22 20:57
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024(Businesswire)
2024-09-03 20:00
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant(Businesswire)
2024-09-03 19:33
EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity(Yahoo Finance)
2024-08-28 07:10
Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference(Businesswire)
2024-08-13 04:25
Vivani Medical: Q2 Earnings Snapshot(Yahoo Finance)
2024-08-13 04:05
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results(Businesswire)
2024-07-11 18:52
Vivani to start in-human trial for GLP-1 implant for treating obesity(Yahoo Finance)
2024-07-10 20:00
Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115(Businesswire)
2024-07-10 19:29
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year(Yahoo Finance)
2024-06-13 00:58
Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant(Yahoo Finance)
2024-06-12 20:25
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED)(Yahoo Finance)
2024-06-12 20:00
Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant(Yahoo Finance)
2024-05-27 21:30
EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use(Yahoo Finance)
2024-05-27 20:00
Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant(Businesswire)
2024-05-13 08:52
VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024(Investorplace)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.